4.8 Article

Mo1919 – Ustekinumab Efficiency As a Higher-Line Therapy in Association with Serum Levels in Patients with Crohn’s Disease

Journal

GASTROENTEROLOGY
Volume 156, Issue 6, Pages S-886-S-887

Publisher

Elsevier BV
DOI: 10.1016/s0016-5085(19)39186-3

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available